Christopher Barden

1.2k total citations
29 papers, 894 citations indexed

About

Christopher Barden is a scholar working on Atomic and Molecular Physics, and Optics, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Christopher Barden has authored 29 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Atomic and Molecular Physics, and Optics, 8 papers in Organic Chemistry and 5 papers in Molecular Biology. Recurrent topics in Christopher Barden's work include Advanced Chemical Physics Studies (8 papers), Spectroscopy and Quantum Chemical Studies (5 papers) and Free Radicals and Antioxidants (4 papers). Christopher Barden is often cited by papers focused on Advanced Chemical Physics Studies (8 papers), Spectroscopy and Quantum Chemical Studies (5 papers) and Free Radicals and Antioxidants (4 papers). Christopher Barden collaborates with scholars based in Canada, United States and India. Christopher Barden's co-authors include Henry F. Schaefer, Jonathan C. Rienstra-Kiracofe, Donald F. Weaver, Mayuri Gupta, Shawn T. Brown, Mark A. Reed, Ross S. Mancini, Paul von Ragué Schleyer, Jason M. Gonzales and Qian‐Shu Li and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and The Journal of Chemical Physics.

In The Last Decade

Christopher Barden

28 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Barden Canada 13 292 269 170 154 101 29 894
Sabyashachi Mishra India 17 208 0.7× 166 0.6× 209 1.2× 231 1.5× 129 1.3× 88 905
Chang‐Guo Zhan United States 13 305 1.0× 391 1.5× 148 0.9× 170 1.1× 47 0.5× 15 837
Jorge M. del Campo Mexico 14 432 1.5× 248 0.9× 389 2.3× 93 0.6× 108 1.1× 39 993
Jason D. Thompson United States 16 294 1.0× 299 1.1× 105 0.6× 119 0.8× 49 0.5× 21 700
Y. Ôno Japan 16 364 1.2× 307 1.1× 417 2.5× 135 0.9× 94 0.9× 44 1.1k
Francisco J. Meléndez Mexico 18 133 0.5× 248 0.9× 239 1.4× 126 0.8× 70 0.7× 89 913
Chia‐Ning Yang Taiwan 16 217 0.7× 278 1.0× 77 0.5× 304 2.0× 44 0.4× 54 857
Esteban Vöhringer‐Martinez Chile 20 465 1.6× 288 1.1× 259 1.5× 315 2.0× 88 0.9× 63 1.3k
Yamil Simón‐Manso United States 19 221 0.8× 239 0.9× 184 1.1× 449 2.9× 105 1.0× 43 1.2k
Roberto A. Boto Spain 14 251 0.9× 573 2.1× 385 2.3× 143 0.9× 164 1.6× 28 1.3k

Countries citing papers authored by Christopher Barden

Since Specialization
Citations

This map shows the geographic impact of Christopher Barden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Barden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Barden more than expected).

Fields of papers citing papers by Christopher Barden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Barden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Barden. The network helps show where Christopher Barden may publish in the future.

Co-authorship network of co-authors of Christopher Barden

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Barden. A scholar is included among the top collaborators of Christopher Barden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Barden. Christopher Barden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muscedere, John, David M. Maslove, Christopher Barden, et al.. (2024). Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19: A Phase 2 Randomized Controlled Double-Blind Study. Critical Care Explorations. 6(2). e1045–e1045. 2 indexed citations
2.
Barden, Christopher, Fan Wu, J. Pedro Fernández-Murray, et al.. (2024). Computer-aided drug design to generate a unique antibiotic family. Nature Communications. 15(1). 8317–8317. 7 indexed citations
3.
Weaver, Donald F., et al.. (2023). Alzheimer’s Disease as an Autoimmune Disease. Alzheimer s & Dementia. 19(S1). 1 indexed citations
4.
Stover, Kurt R., Sanghyun Lee, Seung‐Pil Yang, et al.. (2023). Development and Optimization of a Target Engagement Model of BrainIDO Inhibition for Alzheimer’s Disease. Current Alzheimer Research. 20(10). 705–714. 2 indexed citations
5.
6.
Mancini, Ross S., Christopher Barden, Donald F. Weaver, & Mark A. Reed. (2021). Furazans in Medicinal Chemistry. Journal of Medicinal Chemistry. 64(4). 1786–1815. 40 indexed citations
7.
Wang, Zhiyu, et al.. (2020). Is Inhaled Furosemide a Potential Therapeutic for COVID-19?. The American Journal of the Medical Sciences. 360(3). 216–221. 16 indexed citations
8.
Barden, Christopher, et al.. (2020). Evaluation of Eagle Ford Cyclic Gas Injection EOR: Field Results and Economics. SPE Improved Oil Recovery Conference. 10 indexed citations
9.
Wang, Zhiyu, Yanfei Wang, Seung‐Pil Yang, et al.. (2020). Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide. PeerJ. 8. e9533–e9533. 31 indexed citations
10.
Weaver, Donald F., Christopher Barden, Mayuri Gupta, et al.. (2020). The in silico search for endogenous anti‐Alzheimer's compounds. Alzheimer s & Dementia. 16(S9). 2 indexed citations
11.
Maios, Claudia, Gary A.B. Armstrong, Meijiang Liao, et al.. (2019). The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis. Neurotherapeutics. 16(4). 1149–1166. 26 indexed citations
12.
Weaver, Donald F., et al.. (2017). [P4–031]: ALZHEIMER'S DISEASE AS A DISORDER OF TRYPTOPHAN METABOLISM. Alzheimer s & Dementia. 13(7S_Part_26). 1 indexed citations
13.
Reed, Mark A., Christopher Barden, Erhu Lu, et al.. (2016). P1‐078: Discovery of Small Molecule Dual Inhibitors of Both Abeta and TAU Oligomerization. Alzheimer s & Dementia. 12(7S_Part_8). 1 indexed citations
14.
Jha, Amitabh, Yogesh Yadav, Ajay B. Naidu, et al.. (2014). Design, synthesis and bioevaluation of novel 6-(4-Hydroxypiperidino)naphthalen-2-ol-based potential Selective Estrogen Receptor Modulators for breast cancer. European Journal of Medicinal Chemistry. 92. 103–114. 9 indexed citations
15.
Yadav, Yogesh, Virinder S. Parmar, Jan Balzarini, et al.. (2011). Design, synthesis and bioevaluation of novel candidate selective estrogen receptor modulators. European Journal of Medicinal Chemistry. 46(9). 3858–3866. 24 indexed citations
16.
Barden, Christopher & Donald F. Weaver. (2009). The rise of micropharma. Drug Discovery Today. 15(3-4). 84–87. 15 indexed citations
17.
Barden, Christopher, et al.. (2006). A Non-Born–Oppenheimer Self-consistent Field Method. Journal of Mathematical Chemistry. 42(3). 353–365. 3 indexed citations
18.
Rienstra-Kiracofe, Jonathan C., Christopher Barden, Shawn T. Brown, & Henry F. Schaefer. (2001). Electron Affinities of Polycyclic Aromatic Hydrocarbons. The Journal of Physical Chemistry A. 105(3). 524–528. 123 indexed citations
19.
Barden, Christopher & Henry F. Schaefer. (2000). The singlet–triplet separation in dichlorocarbene: A surprising difference between theory and experiment. The Journal of Chemical Physics. 112(15). 6515–6516. 41 indexed citations
20.
Barden, Christopher, et al.. (1998). Neural Network Correction of PM3-Predicted Infrared Spectra. Journal of Chemical Information and Computer Sciences. 38(3). 483–488. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabyashachi Mishra Breakdown of academic impact, for papers by Chang‐Guo Zhan Breakdown of academic impact, for papers by Jorge M. del Campo Breakdown of academic impact, for papers by Jason D. Thompson Breakdown of academic impact, for papers by Y. Ôno Breakdown of academic impact, for papers by Francisco J. Meléndez Breakdown of academic impact, for papers by Chia‐Ning Yang Breakdown of academic impact, for papers by Esteban Vöhringer‐Martinez Breakdown of academic impact, for papers by Yamil Simón‐Manso Breakdown of academic impact, for papers by Roberto A. Boto
Rankless by CCL
2026